Transcription of Guideline on stability testing for variations to an MA
{{id}} {{{paragraph}}}
European Medicines Agency Inspections Public 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 85 95 E-mail: @EMEA 2005 Reproduction and/or distribution of this document is authorised for non-commercial purposes only provided the EMEA is acknowledged London, 19 May 2005 CPMP/QWP/576/96 Rev 1 EMEA/CVMP/373/04 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) Guideline ON stability testing FOR APPLICATIONS FOR variations TO A MARKETING AUTHORISATION DRAFT AGREED BY QUALITY WORKING PARTY October 2003/ April 2004 (joint)
cpmp/qwp/576/96 rev 1 emea/cvmp/373/04 emea 2005 3/6 guideline on stability testing for applications for variations to a marketing authorisation
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Q5C Stability testing of Biotechnological /, Q5C - Stability testing of Biotechnological / Biological, Stability, Matrixing Designs for Stability Testing, BRACKETING AND MATRIXING DESIGNS FOR, BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING, Stability Workshpo ICH Q1D C, On stability testing for applications for, Stability Testing, IPEC Stability, ANDA Stability Guidance Opportunities & Challenges